FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1986975944> ?p ?o ?g. }

• W1986975944 endingPage "248" @default.
• W1986975944 startingPage "247" @default.
• W1986975944 abstract "Methotrexate is an established and effective systemic treatment for severe psoriasis. Approximately 30% of patients do not respond to standard methotrexate doses while 20% discontinue therapy early in the treatment due to adverse effects, most frequently headache, nausea, gastric complaints and abnormal liver function tests. The purpose of this study was to evaluate the relationships between methotrexate pharmacokinetics and its therapeutic effect/toxicity over the initial 13 weeks of therapy. Forty-one psoriasis patients (table 1) were randomly assigned to methotrexate doses of either 7.5 mg or 15 mg administered once a week either as a bolus or with the weekly dose divided into three aliquots given at 12 hr intervals. The pharmacokinetics of methotrexate were evaluated at baseline and at week 13 and red cell concentrations of methotrexate (ERYMTX) were measured at baseline and at weeks 5, 9 and 13. The grade of skin impairment was evaluated at at weeks 1, 5, 9 and 13 using the PASI-scoring system (The Psoriasis Activity and Severity Index). The score gives an overall index for the clinical degree of psoriasis within the range of 0–72 (Finlay et al. 1990). Plasma concentrations of methotrexate were determined by HPLC (Salamoun & Frantisek 1986). The inhibition activity of erythrocyte methotrexate-polyglutamates was assayed enzymatically with dihydrofolate reductase (Schroder & Heinsvig 1985). The results of the pharmacokinetic and pharmacodynamic analyses are summarized in table 1. There was no difference between weeks 1 and 13 in the pharmacokinetic parameters of plasma methotrexate (P>0.8). Moreover, the intra-individual variability in methotrexate pharmacokinetics was 4 times less than the inter-individual variability (F-test; P<0.01).There was a strong correlation between AUCMTX at week 1 and ERYMTX concentrations at the steady state (rho=0.80, P<0.0001). Pharmacokinetic/pharmacodynamic analysis revealed a highly significant inverse relationships between PASI at week 13 (in % of the initial value) and both AUCMTX at week 1 (rho=−0.80, P<0.0001, fig. 1) and ERYMTX at the steady state (rho=−0.89, P<0.0001). Nine patients with complaints about headache and nausea on the days of methotrexate administration had the maximum plasma methotrexate concentrations (Cmax) of 0.76±0.28 μmol · l−1 as compared to 0.24±0.15 μmol · l−1 in those without this adverse effect (P=0.06). At week 13, eight patients had elevated alanine aminotransferase activities by more than 100% above the baseline. In those patients, AUCMTX at week 1 (4.2±2.4 μmol · hr · l−1) and steady-state ERYMTX (0.104±0.034 μmol · l−1) were higher than in patients with normal liver function tests (1.8±0.09 μmol · hr · l−1, P<0.02, and 0.069±0.020 μmol · l−1, P<0.05). The relationship between AUCMTX at week 1 and PASI at week 13 (in% of the initial value). In conclusion, a strong correlation was observed between methotrexate pharmacokinetics (AUCMTX) and its antipsoriatic effect (PASI). The results of this study suggest that AUCMTX within the range of 2.5–4.0 μmol · hr · l−1 and the divided-dose schedule are associated with a high successrate and a low risk of acute adverse effects of antipsoriatic therapy with methotrexate. This study was supported by the Czech Ministry of Education (Contract No. OC B15.10). The technical assistance of Ivana Tothova is gratefully acknowledged." @default.
• W1986975944 created "2016-06-24" @default.
• W1986975944 creator A5014732302 @default.
• W1986975944 creator A5054114469 @default.
• W1986975944 creator A5060786153 @default.
• W1986975944 creator A5061183072 @default.
• W1986975944 creator A5063355950 @default.
• W1986975944 date "2005-03-01" @default.
• W1986975944 modified "2023-09-27" @default.
• W1986975944 title "Low-Dose Methotrexate Pharmacokinetics and Pharmacodynamics in the Therapy of Severe Psoriasis" @default.
• W1986975944 cites W1992296675 @default.
• W1986975944 cites W2029607894 @default.
• W1986975944 cites W2033218056 @default.
• W1986975944 doi "https://doi.org/10.1111/j.1742-7843.2005.pto960318.x" @default.
• W1986975944 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15733224" @default.
• W1986975944 hasPublicationYear "2005" @default.
• W1986975944 type Work @default.
• W1986975944 sameAs 1986975944 @default.
• W1986975944 citedByCount "31" @default.
• W1986975944 countsByYear W19869759442012 @default.
• W1986975944 countsByYear W19869759442014 @default.
• W1986975944 countsByYear W19869759442015 @default.
• W1986975944 countsByYear W19869759442016 @default.
• W1986975944 countsByYear W19869759442017 @default.
• W1986975944 countsByYear W19869759442020 @default.
• W1986975944 countsByYear W19869759442021 @default.
• W1986975944 countsByYear W19869759442022 @default.
• W1986975944 countsByYear W19869759442023 @default.
• W1986975944 crossrefType "journal-article" @default.
• W1986975944 hasAuthorship W1986975944A5014732302 @default.
• W1986975944 hasAuthorship W1986975944A5054114469 @default.
• W1986975944 hasAuthorship W1986975944A5060786153 @default.
• W1986975944 hasAuthorship W1986975944A5061183072 @default.
• W1986975944 hasAuthorship W1986975944A5063355950 @default.
• W1986975944 hasConcept C111113717 @default.
• W1986975944 hasConcept C112705442 @default.
• W1986975944 hasConcept C126322002 @default.
• W1986975944 hasConcept C16005928 @default.
• W1986975944 hasConcept C197934379 @default.
• W1986975944 hasConcept C19831878 @default.
• W1986975944 hasConcept C2777011040 @default.
• W1986975944 hasConcept C2778375690 @default.
• W1986975944 hasConcept C2778397455 @default.
• W1986975944 hasConcept C2780035454 @default.
• W1986975944 hasConcept C2780564577 @default.
• W1986975944 hasConcept C2780580376 @default.
• W1986975944 hasConcept C2781059491 @default.
• W1986975944 hasConcept C2781382166 @default.
• W1986975944 hasConcept C71924100 @default.
• W1986975944 hasConcept C90924648 @default.
• W1986975944 hasConcept C98274493 @default.
• W1986975944 hasConceptScore W1986975944C111113717 @default.
• W1986975944 hasConceptScore W1986975944C112705442 @default.
• W1986975944 hasConceptScore W1986975944C126322002 @default.
• W1986975944 hasConceptScore W1986975944C16005928 @default.
• W1986975944 hasConceptScore W1986975944C197934379 @default.
• W1986975944 hasConceptScore W1986975944C19831878 @default.
• W1986975944 hasConceptScore W1986975944C2777011040 @default.
• W1986975944 hasConceptScore W1986975944C2778375690 @default.
• W1986975944 hasConceptScore W1986975944C2778397455 @default.
• W1986975944 hasConceptScore W1986975944C2780035454 @default.
• W1986975944 hasConceptScore W1986975944C2780564577 @default.
• W1986975944 hasConceptScore W1986975944C2780580376 @default.
• W1986975944 hasConceptScore W1986975944C2781059491 @default.
• W1986975944 hasConceptScore W1986975944C2781382166 @default.
• W1986975944 hasConceptScore W1986975944C71924100 @default.
• W1986975944 hasConceptScore W1986975944C90924648 @default.
• W1986975944 hasConceptScore W1986975944C98274493 @default.
• W1986975944 hasIssue "3" @default.
• W1986975944 hasLocation W19869759441 @default.
• W1986975944 hasLocation W19869759442 @default.
• W1986975944 hasOpenAccess W1986975944 @default.
• W1986975944 hasPrimaryLocation W19869759441 @default.
• W1986975944 hasRelatedWork W105137006 @default.
• W1986975944 hasRelatedWork W1967512152 @default.
• W1986975944 hasRelatedWork W1990897910 @default.
• W1986975944 hasRelatedWork W1992401971 @default.
• W1986975944 hasRelatedWork W2000659631 @default.
• W1986975944 hasRelatedWork W2030563123 @default.
• W1986975944 hasRelatedWork W2054007511 @default.
• W1986975944 hasRelatedWork W2137251947 @default.
• W1986975944 hasRelatedWork W2168245519 @default.
• W1986975944 hasRelatedWork W2616641857 @default.
• W1986975944 hasVolume "96" @default.
• W1986975944 isParatext "false" @default.
• W1986975944 isRetracted "false" @default.
• W1986975944 magId "1986975944" @default.
• W1986975944 workType "article" @default.